AU626928B2 - Cyclosporin opthalmic compositions - Google Patents

Cyclosporin opthalmic compositions Download PDF

Info

Publication number
AU626928B2
AU626928B2 AU43715/89A AU4371589A AU626928B2 AU 626928 B2 AU626928 B2 AU 626928B2 AU 43715/89 A AU43715/89 A AU 43715/89A AU 4371589 A AU4371589 A AU 4371589A AU 626928 B2 AU626928 B2 AU 626928B2
Authority
AU
Australia
Prior art keywords
composition
eye
present
cyclosporin
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU43715/89A
Other languages
English (en)
Other versions
AU4371589A (en
Inventor
Ronald Edward Peeples
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU4371589A publication Critical patent/AU4371589A/en
Application granted granted Critical
Publication of AU626928B2 publication Critical patent/AU626928B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
AU43715/89A 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions Ceased AU626928B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US262866 1981-05-12
US26286688A 1988-10-26 1988-10-26

Publications (2)

Publication Number Publication Date
AU4371589A AU4371589A (en) 1990-05-03
AU626928B2 true AU626928B2 (en) 1992-08-13

Family

ID=22999400

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43715/89A Ceased AU626928B2 (en) 1988-10-26 1989-10-25 Cyclosporin opthalmic compositions

Country Status (23)

Country Link
JP (1) JPH02164830A (enExample)
KR (1) KR900005973A (enExample)
AU (1) AU626928B2 (enExample)
BE (1) BE1003578A4 (enExample)
CA (1) CA2001502A1 (enExample)
CH (1) CH679210A5 (enExample)
DE (1) DE3935517A1 (enExample)
DK (1) DK531289A (enExample)
ES (1) ES2020032A6 (enExample)
FI (1) FI895064A7 (enExample)
FR (1) FR2638089A1 (enExample)
GB (1) GB2224205B (enExample)
GR (1) GR1000611B (enExample)
HU (1) HU203046B (enExample)
IL (1) IL92120A (enExample)
LU (1) LU87613A1 (enExample)
MY (1) MY106271A (enExample)
NL (1) NL8902657A (enExample)
NO (1) NO894266L (enExample)
NZ (1) NZ231131A (enExample)
PT (1) PT92120B (enExample)
SE (1) SE8903583L (enExample)
ZA (1) ZA898140B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
CA2002147A1 (en) * 1988-11-07 1990-05-07 Shuichi Morikawa Production process for polyimide fibers
US4996193A (en) * 1989-03-03 1991-02-26 The Regents Of The University Of California Combined topical and systemic method of administration of cyclosporine
US5540931A (en) * 1989-03-03 1996-07-30 Charles W. Hewitt Methods for inducing site-specific immunosuppression and compositions of site specific immunosuppressants
FR2670629B1 (fr) * 1990-12-17 1995-03-10 Moving Magnet Tech Actionneur electromagnetique monophase rotatif.
US6262022B1 (en) 1992-06-25 2001-07-17 Novartis Ag Pharmaceutical compositions containing cyclosporin as the active agent
ZA927277B (en) * 1991-10-02 1993-05-19 Boston Ocular Res Dry eye treatment process and solution.
SG45449A1 (en) * 1992-05-13 1998-01-16 Sandoz Ltd Ophthalmic compositions
US5366739A (en) * 1992-08-06 1994-11-22 Deo Corporation Method of ophthalmic drug delivery
US5830508A (en) * 1992-08-06 1998-11-03 Deo Corporation Composition for treating dry eye
DK0589843T3 (da) 1992-09-25 2002-04-02 Novartis Ag Cyclosporinholdige farmaceutiske præparater
US5698533A (en) * 1994-07-26 1997-12-16 Kang; Meng-Che Ophthalmic pharmaceutical composition
ATE218359T1 (de) 1994-11-03 2002-06-15 Novartis Erfind Verwalt Gmbh Neue zubereitungsformen des cyclosporins zur oralen applikation mit einfacher zusammensetzung und hoher bioverfügbarkeit und verfahren zu deren herstellung
US5827822A (en) * 1996-03-25 1998-10-27 Sangstat Medical Corporation Cyclosporin a formulations as nanoparticles
US5834017A (en) * 1995-08-25 1998-11-10 Sangstat Medical Corporation Oral cyclopsporin formulations
US5962019A (en) * 1995-08-25 1999-10-05 Sangstat Medical Corporation Oral cyclosporin formulations
US5766629A (en) * 1995-08-25 1998-06-16 Sangstat Medical Corporation Oral cyclosporin formulations
PT988046E (pt) 1997-01-30 2004-12-31 Novartis Ag Composicoes farmaceuticas sem oleo contendo ciclosporina a
US6254860B1 (en) * 1999-04-13 2001-07-03 Allergan Sales, Inc. Ocular treatment using cyclosporin-A derivatives
US7557082B2 (en) 2006-03-03 2009-07-07 Allergan, Inc. Treatment with cyclosporin A
MX2010004366A (es) * 2007-11-05 2010-05-05 Bausch & Lomb Materiales inmiscibles en agua como vehiculos para suministro de farmacos.
NO2437762T3 (enExample) * 2009-06-05 2018-01-06
KR102487299B1 (ko) 2014-11-25 2023-01-10 알러간, 인코포레이티드 안정화된 오메가-3 안과용 조성물
MX381639B (es) 2016-12-23 2025-03-13 Novaliq Gmbh Composicion oftalmica para el tratamiento de la enfermedad del ojo seco.
CN114449999A (zh) 2019-09-06 2022-05-06 诺瓦利克有限责任公司 用于治疗葡萄膜炎的眼用组合物
EP4201398A1 (en) * 2021-12-24 2023-06-28 Isoxa S.r.l. Isocyclosporin a for topical treatment of ocular diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4839342A (en) * 1987-09-03 1989-06-13 University Of Georgia Research Foundation, Inc. Method of increasing tear production by topical administration of cyclosporin

Also Published As

Publication number Publication date
SE8903583L (sv) 1990-04-27
NZ231131A (en) 1992-06-25
HUT52394A (en) 1990-07-28
GR1000611B (el) 1992-08-31
BE1003578A4 (fr) 1992-04-28
KR900005973A (ko) 1990-05-07
NO894266D0 (no) 1989-10-26
NO894266L (no) 1990-04-27
PT92120A (pt) 1990-04-30
SE8903583D0 (sv) 1989-10-26
HU203046B (en) 1991-05-28
DK531289A (da) 1990-04-27
DE3935517A1 (de) 1990-05-03
PT92120B (pt) 1995-06-30
ZA898140B (en) 1991-06-26
IL92120A0 (en) 1990-07-12
LU87613A1 (fr) 1991-05-07
HU895444D0 (en) 1990-01-28
GB2224205A (en) 1990-05-02
IL92120A (en) 1994-02-27
FI895064A0 (fi) 1989-10-25
JPH02164830A (ja) 1990-06-25
GB2224205B (en) 1992-04-15
MY106271A (en) 1995-04-29
NL8902657A (nl) 1990-05-16
GR890100690A (en) 1990-11-29
AU4371589A (en) 1990-05-03
FR2638089A1 (fr) 1990-04-27
ES2020032A6 (es) 1991-07-16
CH679210A5 (enExample) 1992-01-15
DK531289D0 (da) 1989-10-25
GB8924040D0 (en) 1989-12-13
CA2001502A1 (en) 1990-04-26
FI895064A7 (fi) 1990-04-27

Similar Documents

Publication Publication Date Title
NZ231131A (en) An ophthalmic cyclosporin composition
IT8948485A1 (it) Composizioni oftalmiche a base di una ciclosporina (caso 600-7089)
US5951971A (en) Ophthalmic compositions
Constad et al. Use of an angiotensin converting enzyme inhibitor in ocular hypertension and primary open-angle glaucoma
US6579901B2 (en) Pharmaceutical compositions and methods for treating immune-response associated diseases of the surface and the anterior segment of the eye
EP4025235B1 (en) Ophthalmic composition for the treatment of uveitis
EP2968139B1 (en) Microemulsion topical delivery platform
US4649047A (en) Ophthalmic treatment by topical administration of cyclosporin
JPH0216728B2 (enExample)
JP2006176499A (ja) 眼疾患治療剤
US11654140B2 (en) Treatment of ocular inflammatory diseases using laquinimod
KR20200128407A (ko) 네비볼롤을 포함하는 약제학적 조성물
CZ423797A3 (cs) Topické přípravky s imunosupresivy
JPH0565221A (ja) 眼科用微小球
JPH08508975A (ja) 眼科薬送達ビヒクルとしてのサブミクロン乳剤
Grehn et al. Thymoxamine: a miotic for intraocular use
Fallor et al. Ocular toxicity of experimental intravitreal vitamin E
Yanagawa et al. Application of a drug delivery system to a steroidal ophthalmic preparation with lipid microspheres
Lewis et al. Aminozolamide suspension: the role of the vehicle in a topical carbonic anhydrase inhibitor
HK1004520B (en) Ophthalmic compositions containing a cyclosporin
MXPA00006508A (en) Topical ophthalmic preparations containing immunosuppressive agents